stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

Maravai LifeSciences Holdings, Inc.

United States · NASDAQ: MRVI · Market cap: · P/E: · P/S:

Maravai sells the specialized chemicals and testing products that drugmakers, vaccine makers, and diagnostic labs need to develop and safely manufacture their products.

Maravai LifeSciences sits quietly in the background of modern medicine. It sells the raw ingredients and safety-testing tools that biotech and pharmaceutical companies need to make mRNA vaccines, gene therapies, and diagnostic tests. Without companies like Maravai, the scientists designing new drugs would struggle to turn their ideas into something that can actually be manufactured and given to patients.

Maravai LifeSciences Holdings, Inc. (MRVI) mRNA products (TriLink): line art illustration of a small vial labeled CleanCap mRNA with a short synthetic messenger RNA strand drawn beside it
CleanCap mRNA
CleanCap is a modified mRNA cap used in messenger RNA production.

The business has two main engines. The bigger one is a unit that makes "clean" genetic building blocks called nucleotides, which are the chemical letters used to write mRNA. During the COVID-19 vaccine boom, this business exploded because mRNA vaccine makers needed huge quantities of those building blocks. The second engine handles biologics safety testing: it helps drug companies check that their products are free from contamination before they reach people. The company's fortunes have swung dramatically. Revenue surged during the pandemic, then fell hard as vaccine demand faded, leaving Maravai with a painful hangover and a slumping stock. mRNA remains an important long-term technology for cancer treatments and other medicines, so the company is betting the market will eventually grow again, though the boom years may not return soon. Headquartered in San Diego, Maravai competes with larger life-science suppliers that also sell specialized ingredients and testing services to drug developers.


The simplest way to understand Maravai is this: it doesn't cure anyone. It sells the picks and shovels that other companies use to build cures. When the industry is booming, that can be a wonderful business; when the boom cools, the company feels it fast.

Saved answer · last researched 16 Nov 2026